Compounds > chlorthalidone

chlorthalidone and sq-11725

chlorthalidone has been researched along with sq-11725 in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (41.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (33.33)	29.6817
2010's	3 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL	1
Antoncecchi, E; Balestrazzi, M; Chiarappa, R; De Cesaris, R; Ranieri, G	1
Alveranga, D; Bazilinski, N; Carroll, HJ; Lazar, I; Oh, MS; Uribarri, J	1
Bayley, A; Fraser, HS; Hassell, TA; Nicholson, GD	1
McChesney, JA	1
Gillum, RF	1

Other Studies

12 other study(ies) available for chlorthalidone and sq-11725

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics. PloS one, 2016, Volume: 11, Issue:10 Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat	2016
[Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril]. La Clinica terapeutica, 1986, Mar-31, Volume: 116, Issue:6 Topics: Adult; Aged; Antihypertensive Agents; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines	1986
Minoxidil in a once-a-day step-3 antihypertensive program. Journal of clinical hypertension, 1985, Volume: 1, Issue:1 Topics: Chlorthalidone; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Hypertrichosis; Male; Minoxidil; Nadolol; Pericardial Effusion; Propanolamines	1985
The management of severe hypertension with minoxidil in a once-a-day treatment regimen. Journal of clinical hypertension, 1985, Volume: 1, Issue:4 Topics: Adult; Aged; Chlorthalidone; Creatinine; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Hypertrichosis; Male; Middle Aged; Minoxidil; Nadolol; Patient Compliance; Propanolamines; Reserpine; Time Factors	1985
Once-a-day therapy in patients with moderate-to-severe hypertension. Journal of the National Medical Association, 1984, Volume: 76 Suppl Topics: Adult; Aged; Antihypertensive Agents; Chlorthalidone; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Minoxidil; Nadolol; Propanolamines	1984
Refractory hypertension. Journal of the National Medical Association, 1984, Volume: 76, Issue:11 Topics: Chlorthalidone; Drug Combinations; Female; Humans; Hypertension; Middle Aged; Minoxidil; Nadolol; Propanolamines; Pyrimidines; Reserpine	1984